SCHEMBL6331985

SCHEMBL6331985

COc1ccc2c(C(=O)n3ccc4ccccc43)cccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 7/20 0.54
TUBB1 Q9H4B7 1/20 0.50
MAPT P10636 1/20 0.48
CNR1 P21554 2/20 0.47
RAB9A P51151 2/20 0.47
TSHR P16473 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NOTUM Q6P988 1/20 0.46
CDC25B P30305 1/20 0.45
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
MAOB P27338 1/20 0.44
FABP4 P15090 1/20 0.44
AURKA O14965 1/20 0.43
MET P08581 1/20 0.43
KDR P35968 1/20 0.43
TEK Q02763 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6400993 0.90 MTNR1A (0.55) CNR2TUBB1MAPTCNR1RAB9A
SCHEMBL6331989 0.88 MAPT (0.51) CNR2TUBB1MAPTCNR1ALDH1A1
SCHEMBL21777692 0.81 TSHR (0.60) CNR2MAPTCNR1RAB9ATSHR
SCHEMBL31435515 0.79 RAB9A (0.63) TUBB1RAB9ATSHRL3MBTL1NOTUM
SCHEMBL9747620 0.75 MTNR1A (0.55) CNR2CDC25BALDH1A1KDM4EHPGD
SCHEMBL31613816 0.75 CDC25B (0.64) CNR2MAPTRAB9ACDC25BALDH1A1
SCHEMBL2510203 0.75 CDC25B (0.64) CNR2MAPTRAB9ACDC25BALDH1A1
SCHEMBL2237855 0.74 MTNR1A (0.56) CNR2L3MBTL1CDC25BALDH1A1KDM4E
SCHEMBL31613069 0.74 KDR (0.67) CNR2CDC25BALDH1A1KDM4EAURKA
SCHEMBL2509951 0.74 MTNR1A (0.52) CNR2CDC25BAURKAMETKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009903-A1 CB2-selective cannabinoid analogues CLEMSON UNIVERSITY 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009903-A1 CB2-selective cannabinoid analogues CNR2, CNR1, GPR68 CNR2 1/4885TUBB1 815/4885MAPT 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.